TITLE

Poster presentation 2002

AUTHOR(S)
Sutton, Steven W.; Patel, Amit N.; Schmidt, Lori A.; Hunley, Eric K.; Yancey, Lloyd W.; Hebeler, Robert F.; Cheung, Edson H.; Henry III, A. Carl; Hamman, Baron L.; Wood, Richard E.; Samankatiwat, Piya; Chen, Q.; Shepard, S.; Clinton, V.
PUB. DATE
January 2003
SOURCE
Perfusion;Jan2003 Supplement, Vol. 18, p89
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Presents information on cardioplegic leukocyte depletion during cardiopulmonary bypass. Benefits of leukocyte filters for improved oxygenation and decreased length of hospital stay; Method for attenuating myocardial ischaemia reperfusion injury; Reduction in activated neutrophils by leukocyte-depleting blood cardioplegia medium.
ACCESSION #
9716778

 

Related Articles

  • Prebypass filtration of cardiopulmonary bypass circuits: an outdated technique? Merkle, Frank; Böttcher, Wolfgang; Hetzer, Roland // Perfusion;Jan2003 Supplement, Vol. 18, p81 

    Filtration of cardiopulmonary bypass (CPB) priming fluid before connection of the circuit to the patient was first accomplished by arterial line filtration. When dedicated prebypass filters (PBFs) with smaller pore sizes became available, a large number of particles could be found on the filter...

  • Light and electron microscopic analyses for ischaemia-reperfusion lung injury in an ovine cardiopulmonary bypass model. Kim, W.G.; Lee, B-H.; Seo, J.W. // Perfusion;May2001, Vol. 16 Issue 3, p207 

    An experiment to study the role of contact-activation leukocyte sequestration in the formation of ischaemia-reperfusion injury (I-R injury) was carried out. The study was conducted using light and electron microscopic analyses in an ovine cardiopulmonary bypass (CPB) model using a membrane...

  • Strategic leukocyte depletion reduces pulmonary microvascular pressure and improves pulmonary status post-cardiopulmonary bypass. Olivencia-Yurvati, AH; Ferrara, CA; Tierney, N; Wallace, N; Mallet, RT // Perfusion;Jan2003 Supplement, Vol. 18, p23 

    Cardiopulmonary bypass (CPB) precipitates inflammation that causes marked pulmonary dysfunction. Leukocyte filtration has been proposed to reduce these deleterious effects. Other studies show an improvement with aprotinin. We proposed that a combination of these two therapies would...

  • Intra-Aortic Filtration. Christenson, Jan T.; Vala, Dominique L.; Licker, Marc; Sierra, Jorge; Kalangos, Afksendiyos // Texas Heart Institute Journal;2005, Vol. 32 Issue 4, p515 

    Particulate emboli are an important factor in the development of complications after cardiac surgery. The use of an intra-aortic filter during aortic declamping has proved safe and effective in reducing the incidence of embolic complications. Because aortic cross-clamping is also associated with...

  • Editorial. Gourlay, T. // Perfusion;Jan2004 Supplement 1, Vol. 19, p1 

    Editorial. Focuses on the publication of the proceedings of the Third International Workshop on Therapeutic Filtration held in July 2003 at the Hammersmith Hospital campus of Imperial College London in England. Application of conventional filtration to cardiopulmonary bypass and albumin dialysis...

  • Leukodepletion and aprotinin improve clinical outcome after extracorporeal circulation. Gott, J. // Perfusion;Mar2001 Supplement 1, Vol. 16, p5 

    Most cardiac operations involve the use of extracorporeal circulation with its attendant systemic inflammatory response syndrome. Many anti-inflammatory strategies hold promise for reducing the associated morbidity of cardiopulmonary bypass. The application of pharmacological and mechanical...

  • Timing of leukocyte filtration during cardiopulmonary bypass. Matheis, G.; Scholz, M.; Simon, A.; Henrich, D.; Wimmer-Greinecker, G.; Moritz, A. // Perfusion;Mar2001 Supplement 1, Vol. 16, p31 

    The effects of leukocyte filtration on the outcome of cardiac surgery with cardiopulmonary bypass (CPB) have been shown by numerous investigators. In the majority of cases a leukocyte filter is placed in the arterial line instead of a standard arterial line filter and used throughout CPB....

  • Leukocyte filtration in cardiac surgery: a review. Matheis, G.; Scholz, M.; Simon, A.; Dzemali, O.; Moritz, A. // Perfusion;Sep2001, Vol. 16 Issue 5, p361 

    Leukocyte filtration has evolved as an important technique in cardiac surgery with cardiopulmonary bypass to prevent pathogenic effector functions mediated by activated leukocytes. The underlying mechanisms that result in an improvement of laboratory variables as well as clinical outcome are not...

  • The GP IIb/IIIa inhibitor abciximab (ReoPro®) decreases activation and interaction of platelets and leukocytes during in vitro cardiopulmonary bypass simulation Straub, Andreas; Wendel, Hans Peter; Azevedo, Ruben; Ziemer, Gerhard // European Journal of Cardio-Thoracic Surgery;Apr2005, Vol. 27 Issue 4, p617 

    Abstract: Objective: Cardiopulmonary bypass (CPB) induces a systemic inflammatory response and increases expression of the platelet activation marker P-selectin which mediates binding of platelets to leukocytes. Inhibition of the platelet GP IIb/IIIa receptor during CPB has been shown to protect...

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics